Get started
Work

Abstract 5586: Phase I study of PARP inhibitor ABT-888 and carboplatin with novel imaging in metastatic breast cancer (MBC) (NCI-8609)

Year: 2012
Type: conference-abstract
DOI: 10.1158/1538-7445.am2012-5586
Authors: Bhuvaneswari Ramaswamy, Maryam B. Lustberg, Robert Wesolowski, Rachel M. Layman, Ewa Mrozek, Erin M. Olson, Eleni Andreopoulou, Alejandra Garcia-Villa, Jeff Chalmers, Jeffrey A. Cotrill, Julie Nutter, Jamie Ledin, Larry J. Schaaf, Saeed Bajestani, Weiqiang Zhao, Susan Geyer, Alice Chen, Charles L. Shapiro, Miguel A. Villalona-Calero, Michael Knopp, Michael R. Grever
Institutions: The Ohio State University, Albert Einstein College of Medicine, Montefiore Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, National Institutes of Health, National Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W1987409006
Cites:
Cited by:
Related to: 10